0
Editorials |

The CODEX IndexCODEX: A Collection or Digest of Laws: A Code

Gavin C. Donaldson, PhD; Jadwiga A. Wedzicha, MD
Author and Funding Information

From the Centre for Respiratory Medicine, University College London, Royal Free Hospital.

Correspondence to: Gavin C. Donaldson, PhD, Centre for Respiratory Medicine, University College London, Royal Free Hospital, Rowland Hill St, London, NW3 2PF, England; e-mail: g.donaldson@ucl.ac.uk


Financial/nonfinancial disclosures: The authors have reported to CHEST that no potential conflicts of interest exist with any companies/organizations whose products or services may be discussed in this article.

Reproduction of this article is prohibited without written permission from the American College of Chest Physicians. See online for more details.


Chest. 2014;145(5):934-935. doi:10.1378/chest.13-2678
Text Size: A A A
Published online

Extract

Prognostic scoring systems are useful in clinical practice to identify patients at highest risk from death, to support decisions regarding how aggressively to intervene with therapies, or to inform decisions that palliative care is in the patient’s best interest. The scores can also be used to stratify patients for inclusion into clinical trials, the results from which will hopefully improve care and life expectancy.

The recent updates to the GOLD (Global Initiative for Chronic Obstructive Lung Disease) strategy documents on COPD have placed much more emphasis on multidimensional assessment tools and future risk reduction associated with COPD, including improved management and prevention of COPD exacerbations.1 These events are key events in the natural history of COPD and are important causes of morbidity and mortality in the condition. Some patients are especially susceptible to development of exacerbations and are termed frequent exacerbators with increased airway and systemic inflammation and worse prognosis than patients with a history of infrequent exacerbations.2 Frequent exacerbators have a higher risk of hospital admission and also recurrent exacerbations3 causing hospital readmission especially within 3 months of an index admission, which is costly for health-care services all over the world. In a large Canadian COPD database study, Suissa and colleagues4 also showed that from one hospital admission to the next, with progressive disease, the chance of readmission increases.

First Page Preview

View Large
First page PDF preview

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543